Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 37 entries
Sorted by: Best Match Show Resources per page
Advancing the educational and career pathway for clinical trials nurses

Educational trials

Roydhouse JK.
GSID: yW9m0lPrYpQJ
K Scott, K White, JK Roydhouse - The Journal of Continuing …, 2013 - journals.healio.com

… that educational and training opportunities for nurses who are pursu- Clinical trials nurses play a pivotal role in the conduct of clinical research, but the educational and … This article reports findings from a survey of nurses working...

Cite
Scott, K., White, K., & Roydhouse, J. K. (2013). Advancing the educational and career pathway for clinical trials nurses. The Journal of Continuing Education in Nursing, 44(4), 165-170.
Scott, Kathleen, Kathryn White, and Jessica K. Roydhouse. "Advancing the educational and career pathway for clinical trials nurses." The Journal of Continuing Education in Nursing 44.4 (2013): 165-170.
Copy Download .nbib Format: MLA
Adrenocorticotropic Hormone-Dependent Cushing's Syndrome: Use of an octreotide trial to distinguish between pituitary or ectopic sources.

Sultan Qaboos University medical journal

El-Shafie OT, Al-Saffi N, Al-Sajwani A, Woodhouse N.
PMID: 25685371
Sultan Qaboos Univ Med J. 2015 Feb;15(1):e120-3. Epub 2015 Jan 21.

OBJECTIVES: Adrenocorticotropic hormone (ACTH) overproduction is usually due to a pituitary tumour which is often not visible on magnetic resonance imaging (MRI). However, ACTH overproduction may be due to an ectopic source. This study aimed to develop a simple...

Cite
El-Shafie OT, Al-Saffi N, Al-Sajwani A, et al. Adrenocorticotropic Hormone-Dependent Cushing's Syndrome: Use of an octreotide trial to distinguish between pituitary or ectopic sources. Sultan Qaboos Univ Med J. 2015;15(1):e120-3
El-Shafie, O. T., Al-Saffi, N., Al-Sajwani, A., & Woodhouse, N. (2015). Adrenocorticotropic Hormone-Dependent Cushing's Syndrome: Use of an octreotide trial to distinguish between pituitary or ectopic sources. Sultan Qaboos University medical journal, 15(1), e120-3.
El-Shafie, Omayma T, et al. "Adrenocorticotropic Hormone-Dependent Cushing's Syndrome: Use of an octreotide trial to distinguish between pituitary or ectopic sources." Sultan Qaboos University medical journal vol. 15,1 (2015): e120-3.
El-Shafie OT, Al-Saffi N, Al-Sajwani A, Woodhouse N. Adrenocorticotropic Hormone-Dependent Cushing's Syndrome: Use of an octreotide trial to distinguish between pituitary or ectopic sources. Sultan Qaboos Univ Med J. 2015 Feb;15(1):e120-3. Epub 2015 Jan 21. PMID: 25685371; PMCID: PMC4318592.
Copy Download .nbib Format: NLM
Radical-carbanion cyclo-coupling in armed aromatics: overriding steric hindrance to ring closure.

Chemical communications (Cambridge, England)

Roydhouse MD, Walton JC.
PMID: 16136248
Chem Commun (Camb). 2005 Sep 21;(35):4453-5. doi: 10.1039/b506391d. Epub 2005 Aug 04.

Omega-(2-Halophenyl)alkyl-2-oxazolines were prepared and reacted via base promoted intramolecular coupling of radical with carbanionic centres to yield 1-phenyl-1-oxazolino-indan and -tetralin derivatives containing quaternary C-atoms.

Cite
Roydhouse MD, Walton JC. Radical-carbanion cyclo-coupling in armed aromatics: overriding steric hindrance to ring closure. Chem Commun (Camb). 2005;(35):4453-5doi: 10.1039/b506391d.
Roydhouse, M. D., & Walton, J. C. (2005). Radical-carbanion cyclo-coupling in armed aromatics: overriding steric hindrance to ring closure. Chemical communications (Cambridge, England), (35), 4453-5. https://doi.org/10.1039/b506391d
Roydhouse, Mark D, and Walton, John C. "Radical-carbanion cyclo-coupling in armed aromatics: overriding steric hindrance to ring closure." Chemical communications (Cambridge, England) vol. ,35 (2005): 4453-5. doi: https://doi.org/10.1039/b506391d
Roydhouse MD, Walton JC. Radical-carbanion cyclo-coupling in armed aromatics: overriding steric hindrance to ring closure. Chem Commun (Camb). 2005 Sep 21;(35):4453-5. doi: 10.1039/b506391d. Epub 2005 Aug 04. PMID: 16136248.
Copy Download .nbib Format: NLM
Axial and equatorial cyclohexylacyl and tetrahydropyranyl-2-acyl radicals. An experimental and theoretical study.

Organic letters

DiLabio GA, Ingold KU, Roydhouse MD, Walton JC.
PMID: 15524473
Org Lett. 2004 Nov 11;6(23):4319-22. doi: 10.1021/ol0481683.

Axial and equatorial cyclohexylacyl and tetrahydropyranyl-2-acyl radicals gave distinct EPR spectra thanks to surprisingly large beta-hydrogen atom hyperfine splittings that enabled them to be characterized and monitored. DFT computations indicated that the axial species (X = CH(2)) had a...

Cite
DiLabio GA, Ingold KU, Roydhouse MD, et al. Axial and equatorial cyclohexylacyl and tetrahydropyranyl-2-acyl radicals. An experimental and theoretical study. Org Lett. 2004;6(23):4319-22doi: 10.1021/ol0481683.
DiLabio, G. A., Ingold, K. U., Roydhouse, M. D., & Walton, J. C. (2004). Axial and equatorial cyclohexylacyl and tetrahydropyranyl-2-acyl radicals. An experimental and theoretical study. Organic letters, 6(23), 4319-22. https://doi.org/10.1021/ol0481683
DiLabio, Gino A, et al. "Axial and equatorial cyclohexylacyl and tetrahydropyranyl-2-acyl radicals. An experimental and theoretical study." Organic letters vol. 6,23 (2004): 4319-22. doi: https://doi.org/10.1021/ol0481683
DiLabio GA, Ingold KU, Roydhouse MD, Walton JC. Axial and equatorial cyclohexylacyl and tetrahydropyranyl-2-acyl radicals. An experimental and theoretical study. Org Lett. 2004 Nov 11;6(23):4319-22. doi: 10.1021/ol0481683. PMID: 15524473.
Copy Download .nbib Format: NLM
Catecholamine-secreting carotid body paraganglioma: successful preoperative control of hypertension and clinical symptoms using high-dose long-acting octreotide.

Endocrinology, diabetes & metabolism case reports

Elshafie O, Al Badaai Y, Alwahaibi K, Qureshi A, Hussein S, Al Azzri F, Almamari A, Woodhouse N.
PMID: 25136449
Endocrinol Diabetes Metab Case Rep. 2014;2014:140051. doi: 10.1530/EDM-14-0051. Epub 2014 Jul 01.

UNLABELLED: A 48-year-old hypertensive and diabetic patient presented with a 10-year history of progressive right facial pain, tinnitus, hearing loss, sweating, and palpitations. Investigations revealed a 5.6 cm vascular tumor at the carotid bifurcation. Her blood pressure (BP) was...

Cite
Elshafie O, Al Badaai Y, Alwahaibi K, et al. Catecholamine-secreting carotid body paraganglioma: successful preoperative control of hypertension and clinical symptoms using high-dose long-acting octreotide. Endocrinol Diabetes Metab Case Rep. 2014;2014:140051doi: 10.1530/EDM-14-0051.
Elshafie, O., Al Badaai, Y., Alwahaibi, K., Qureshi, A., Hussein, S., Al Azzri, F., Almamari, A., & Woodhouse, N. (2014). Catecholamine-secreting carotid body paraganglioma: successful preoperative control of hypertension and clinical symptoms using high-dose long-acting octreotide. Endocrinology, diabetes & metabolism case reports, 2014140051. https://doi.org/10.1530/EDM-14-0051
Elshafie, Omayma, et al. "Catecholamine-secreting carotid body paraganglioma: successful preoperative control of hypertension and clinical symptoms using high-dose long-acting octreotide." Endocrinology, diabetes & metabolism case reports vol. 2014 (2014): 140051. doi: https://doi.org/10.1530/EDM-14-0051
Elshafie O, Al Badaai Y, Alwahaibi K, Qureshi A, Hussein S, Al Azzri F, Almamari A, Woodhouse N. Catecholamine-secreting carotid body paraganglioma: successful preoperative control of hypertension and clinical symptoms using high-dose long-acting octreotide. Endocrinol Diabetes Metab Case Rep. 2014;2014:140051. doi: 10.1530/EDM-14-0051. Epub 2014 Jul 01. PMID: 25136449; PMCID: PMC4120363.
Copy Download .nbib Format: NLM
Investigating Potential Bias in Patient-Reported Outcomes in Open-label Cancer Trials.

JAMA oncology

Roydhouse JK, Fiero MH, Kluetz PG.
PMID: 30653227
JAMA Oncol. 2019 Apr 01;5(4):457-458. doi: 10.1001/jamaoncol.2018.6205.

No abstract available.

Cite
Roydhouse JK, Fiero MH, Kluetz PG. Investigating Potential Bias in Patient-Reported Outcomes in Open-label Cancer Trials. JAMA Oncol. 2019;5(4):457-458doi: 10.1001/jamaoncol.2018.6205.
Roydhouse, J. K., Fiero, M. H., & Kluetz, P. G. (2019). Investigating Potential Bias in Patient-Reported Outcomes in Open-label Cancer Trials. JAMA oncology, 5(4), 457-458. https://doi.org/10.1001/jamaoncol.2018.6205
Roydhouse, Jessica K, et al. "Investigating Potential Bias in Patient-Reported Outcomes in Open-label Cancer Trials." JAMA oncology vol. 5,4 (2019): 457-458. doi: https://doi.org/10.1001/jamaoncol.2018.6205
Roydhouse JK, Fiero MH, Kluetz PG. Investigating Potential Bias in Patient-Reported Outcomes in Open-label Cancer Trials. JAMA Oncol. 2019 Apr 01;5(4):457-458. doi: 10.1001/jamaoncol.2018.6205. PMID: 30653227.
Copy Download .nbib Format: NLM
Accuracy of documented administration times for intravenous antimicrobial drugs and impact on dosing decisions.

British journal of clinical pharmacology

Roydhouse SA, Carland JE, Debono DS, Baysari MT, Reuter SE, Staciwa AJ, Sandhu APK, Day RO, Stocker SL.
PMID: 33792079
Br J Clin Pharmacol. 2021 Nov;87(11):4273-4282. doi: 10.1111/bcp.14844. Epub 2021 Apr 15.

AIMS: Accurate documentation of medication administration time is imperative for many therapeutic decisions, including dosing of intravenous antimicrobials. The objectives were to determine (1) the discrepancy between actual and documented administration times for antimicrobial infusions and (2) whether day...

Cite
Roydhouse SA, Carland JE, Debono DS, et al. Accuracy of documented administration times for intravenous antimicrobial drugs and impact on dosing decisions. Br J Clin Pharmacol. 2021;87(11):4273-4282doi: 10.1111/bcp.14844.
Roydhouse, S. A., Carland, J. E., Debono, D. S., Baysari, M. T., Reuter, S. E., Staciwa, A. J., Sandhu, A. P. K., Day, R. O., & Stocker, S. L. (2021). Accuracy of documented administration times for intravenous antimicrobial drugs and impact on dosing decisions. British journal of clinical pharmacology, 87(11), 4273-4282. https://doi.org/10.1111/bcp.14844
Roydhouse, Stephanie A, et al. "Accuracy of documented administration times for intravenous antimicrobial drugs and impact on dosing decisions." British journal of clinical pharmacology vol. 87,11 (2021): 4273-4282. doi: https://doi.org/10.1111/bcp.14844
Roydhouse SA, Carland JE, Debono DS, Baysari MT, Reuter SE, Staciwa AJ, Sandhu APK, Day RO, Stocker SL. Accuracy of documented administration times for intravenous antimicrobial drugs and impact on dosing decisions. Br J Clin Pharmacol. 2021 Nov;87(11):4273-4282. doi: 10.1111/bcp.14844. Epub 2021 Apr 15. PMID: 33792079.
Copy Download .nbib Format: NLM
The estimand framework and its application in substance use disorder clinical trials: a case study.

The American journal of drug and alcohol abuse

Roydhouse JK, Floden L, Tomko RL, Gray KM, Bell ML.
PMID: 34702088
Am J Drug Alcohol Abuse. 2021 Oct 26;1-6. doi: 10.1080/00952990.2021.1976199. Epub 2021 Oct 26.

Relapse rates among individuals with substance use disorder (SUD) remain high and new treatment approaches are needed, which require evaluation in randomized controlled trials (RCTs). Measurement and interpretation challenges for SUD RCT data are often ignored or presented only...

Cite
Roydhouse JK, Floden L, Tomko RL, et al. The estimand framework and its application in substance use disorder clinical trials: a case study. Am J Drug Alcohol Abuse. 2021;1-6doi: 10.1080/00952990.2021.1976199.
Roydhouse, J. K., Floden, L., Tomko, R. L., Gray, K. M., & Bell, M. L. (2021). The estimand framework and its application in substance use disorder clinical trials: a case study. The American journal of drug and alcohol abuse, 1-6. https://doi.org/10.1080/00952990.2021.1976199
Roydhouse, Jessica K, et al. "The estimand framework and its application in substance use disorder clinical trials: a case study." The American journal of drug and alcohol abuse vol. (2021): 1-6. doi: https://doi.org/10.1080/00952990.2021.1976199
Roydhouse JK, Floden L, Tomko RL, Gray KM, Bell ML. The estimand framework and its application in substance use disorder clinical trials: a case study. Am J Drug Alcohol Abuse. 2021 Oct 26;1-6. doi: 10.1080/00952990.2021.1976199. Epub 2021 Oct 26. PMID: 34702088.
Copy Download .nbib Format: NLM
The use of proxies and proxy-reported measures: a report of the international society for quality of life research (ISOQOL) proxy task force.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Roydhouse JK, Cohen ML, Eshoj HR, Corsini N, Yucel E, Rutherford C, Wac K, Berrocal A, Lanzi A, Nowinski C, Roberts N, Kassianos AP, Sebille V, King MT, Mercieca-Bebber R.
PMID: 34254262
Qual Life Res. 2021 Jul 12; doi: 10.1007/s11136-021-02937-8. Epub 2021 Jul 12.

AIMS: Proxy reports are often used when patients are unable to self-report. It is unclear how proxy measures are currently in use in adult health care and research settings. We aimed to describe how proxy reports are used in...

Cite
Roydhouse JK, Cohen ML, Eshoj HR, et al. The use of proxies and proxy-reported measures: a report of the international society for quality of life research (ISOQOL) proxy task force. Qual Life Res. 2021;doi: 10.1007/s11136-021-02937-8.
Roydhouse, J. K., Cohen, M. L., Eshoj, H. R., Corsini, N., Yucel, E., Rutherford, C., Wac, K., Berrocal, A., Lanzi, A., Nowinski, C., Roberts, N., Kassianos, A. P., Sebille, V., King, M. T., Mercieca-Bebber, R. (2021). The use of proxies and proxy-reported measures: a report of the international society for quality of life research (ISOQOL) proxy task force. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, . https://doi.org/10.1007/s11136-021-02937-8
Roydhouse, Jessica K, et al. "The use of proxies and proxy-reported measures: a report of the international society for quality of life research (ISOQOL) proxy task force." Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation vol. (2021). doi: https://doi.org/10.1007/s11136-021-02937-8
Roydhouse JK, Cohen ML, Eshoj HR, Corsini N, Yucel E, Rutherford C, Wac K, Berrocal A, Lanzi A, Nowinski C, Roberts N, Kassianos AP, Sebille V, King MT, Mercieca-Bebber R. The use of proxies and proxy-reported measures: a report of the international society for quality of life research (ISOQOL) proxy task force. Qual Life Res. 2021 Jul 12; doi: 10.1007/s11136-021-02937-8. Epub 2021 Jul 12. PMID: 34254262.
Copy Download .nbib Format: NLM
VIPoma Crisis: Immediate and life saving reduction of massive stool volumes on starting treatment with octreotide.

Sultan Qaboos University medical journal

Elshafie O, Grant C, Al-Hamdani A, Jain R, Woodhouse N.
PMID: 21509215
Sultan Qaboos Univ Med J. 2011 Feb;11(1):104-7. Epub 2011 Feb 12.

We report the case of a 57-year-old male physician who presented with a life threatening secretory and refractory diarrhoea of around 20 L/day. This was complicated by severe hypotension, hypokalaemia, hypercalcaemia, renal failure requiring dialysis, metabolic acidosis, cardiorespiratory arrest...

Cite
Elshafie O, Grant C, Al-Hamdani A, et al. VIPoma Crisis: Immediate and life saving reduction of massive stool volumes on starting treatment with octreotide. Sultan Qaboos Univ Med J. 2011;11(1):104-7
Elshafie, O., Grant, C., Al-Hamdani, A., Jain, R., & Woodhouse, N. (2011). VIPoma Crisis: Immediate and life saving reduction of massive stool volumes on starting treatment with octreotide. Sultan Qaboos University medical journal, 11(1), 104-7.
Elshafie, Omayma, et al. "VIPoma Crisis: Immediate and life saving reduction of massive stool volumes on starting treatment with octreotide." Sultan Qaboos University medical journal vol. 11,1 (2011): 104-7.
Elshafie O, Grant C, Al-Hamdani A, Jain R, Woodhouse N. VIPoma Crisis: Immediate and life saving reduction of massive stool volumes on starting treatment with octreotide. Sultan Qaboos Univ Med J. 2011 Feb;11(1):104-7. Epub 2011 Feb 12. PMID: 21509215; PMCID: PMC3074686.
Copy Download .nbib Format: NLM
The estimand framework and its application in substance use disorder clinical trials: a case study.

The American journal of drug and alcohol abuse

Roydhouse JK, Floden L, Tomko RL, Gray KM, Bell ML.
PMID: 34702088
Am J Drug Alcohol Abuse. 2021 Nov 02;47(6):658-663. doi: 10.1080/00952990.2021.1976199. Epub 2021 Oct 26.

Relapse rates among individuals with substance use disorder (SUD) remain high and new treatment approaches are needed, which require evaluation in randomized controlled trials (RCTs). Measurement and interpretation challenges for SUD RCT data are often ignored or presented only...

Cite
Roydhouse JK, Floden L, Tomko RL, et al. The estimand framework and its application in substance use disorder clinical trials: a case study. Am J Drug Alcohol Abuse. 2021;47(6):658-663doi: 10.1080/00952990.2021.1976199.
Roydhouse, J. K., Floden, L., Tomko, R. L., Gray, K. M., & Bell, M. L. (2021). The estimand framework and its application in substance use disorder clinical trials: a case study. The American journal of drug and alcohol abuse, 47(6), 658-663. https://doi.org/10.1080/00952990.2021.1976199
Roydhouse, Jessica K, et al. "The estimand framework and its application in substance use disorder clinical trials: a case study." The American journal of drug and alcohol abuse vol. 47,6 (2021): 658-663. doi: https://doi.org/10.1080/00952990.2021.1976199
Roydhouse JK, Floden L, Tomko RL, Gray KM, Bell ML. The estimand framework and its application in substance use disorder clinical trials: a case study. Am J Drug Alcohol Abuse. 2021 Nov 02;47(6):658-663. doi: 10.1080/00952990.2021.1976199. Epub 2021 Oct 26. PMID: 34702088.
Copy Download .nbib Format: NLM
Radioactive iodine-131 therapy in the management of ectopic thyroid tissue.

Sultan Qaboos University medical journal

El-Shafie OT, Hussain S, Sankhla D, Woodhouse N.
PMID: 25364564
Sultan Qaboos Univ Med J. 2014 Nov;14(4):e571-4. Epub 2014 Oct 14.

The occurrence of ectopic lingual thyroid tissue was first reported over 100 years ago. We report an unusual presentation of ectopic thyroid tissue occurring in the submental area. A 27-year-old female presented to the Sultan Qaboos University Hospital in...

Cite
El-Shafie OT, Hussain S, Sankhla D, et al. Radioactive iodine-131 therapy in the management of ectopic thyroid tissue. Sultan Qaboos Univ Med J. 2014;14(4):e571-4
El-Shafie, O. T., Hussain, S., Sankhla, D., & Woodhouse, N. (2014). Radioactive iodine-131 therapy in the management of ectopic thyroid tissue. Sultan Qaboos University medical journal, 14(4), e571-4.
El-Shafie, Omayma T, et al. "Radioactive iodine-131 therapy in the management of ectopic thyroid tissue." Sultan Qaboos University medical journal vol. 14,4 (2014): e571-4.
El-Shafie OT, Hussain S, Sankhla D, Woodhouse N. Radioactive iodine-131 therapy in the management of ectopic thyroid tissue. Sultan Qaboos Univ Med J. 2014 Nov;14(4):e571-4. Epub 2014 Oct 14. PMID: 25364564; PMCID: PMC4205073.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 37 entries